CSPC's drug differs from the others ... important and a key part of our strategy," said Sharon Barr, AZ's head of biopharmaceuticals R&D. Astellas has licensed rights to a smart stethoscope ...

Overview: CSPC Pharmaceutical Group Limited is an investment holding company involved in the research, development, manufacture, and sale of pharmaceutical products across China and ...

This advancement positions CSPC as a significant player in addressing unmet medical needs in the oncology sector. For further insights into HK:1093 stock, check out TipRanks’ Stock Analysis page.

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks CSPC Pharmaceutical Group has entered into an exclusive license agreement with BeiGene for the global ...

Jefferies analyst David Shang maintained a Hold rating on CSPC Pharmaceutical Group (CHJTF – Research Report) today and set a price target of ...

CSPC Pharmaceutical Group Ltd. on Jan. 13 gained the National Medical Products Administration’s approval of Shanzeping (prusogliptin tablets; DBPR-108) as a novel oral dipeptidyl peptidase-IV (DPP-4) ...

Shell Nanhai BV and CNOOC have taken final investment decision to proceed with the proposed third major expansion of ethylene production capacity at the CSPC petrochemical complex in Guangdong ...

Overview: CSPC Pharmaceutical Group Limited is an investment holding company involved in the research, development, manufacture, and sale of pharmaceutical products across China and internationally, ...